GHRS

NASDAQ · Pharmaceuticals

Gh Research Plc

Mid-Cap Stocks Pharmaceutical Stocks Healthcare Stocks

$30.27

-0.37 (-1.21%)

As of Aug 9, 10:14 PM ET ·

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 16 94%

Hold 1 6%

Sell 0 0%

Price Target

Analyst Price Target +59.3% upside

Low Target $34.28

Average Target $48.23

High Target $66.93

Current Price $30.27

Current
$30.27

Target
$48.23

$34.28 $48.23 avg $66.93

Scenario Analysis

Bear Case

$34.28

13.2%

Low target

Base Case

$48.23

+59.3%

Avg target

Bull Case

$66.93

+121.1%

High target

Risk/Reward

9.1x

Highly favorable

Price in Context

52-Week High

$31.00

-2.4% from high

52-Week Low

$11.32

+167.4% from low

Target vs 52W High

$48.23

+55.6% vs high

Next Earnings Report

Aug 26, 2026

15d

until earnings

EPS Est: $-0.31

Peer Consensus — Pharmaceuticals

Stock	Consensus	Analysts	Buy %	Target	Upside
LLY Eli Lilly and Co.	Strong Buy	38	79%	$1,330.33	+12.2%
RDY Dr. Reddy's Laboratories	Strong Sell	45	31%	—	+0.0%
JNJ Johnson & Johnson	Buy	31	71%	$299.55	+15.5%
MRK Merck & Co. Inc.	Buy	36	69%	$159.27	+23.9%
PFE Pfizer Inc.	Hold	36	39%	$33.90	+26.7%
BMY Bristol-Myers Squibb Co	Hold	35	40%	$174.50	+169.6%
RPRX Royalty Pharma Plc- Cl A	Strong Buy	16	88%	$36.26	-36.1%
ZTS Zoetis Inc	Hold	24	54%	$209.87	+188.8%